Meeting
2024 ASCO Annual Meeting
Management of relapsed stage I nonseminomatous germ-cell tumor with retroperitoneal only relapse.
Authors
Ahmed Bilal Khalid
Indiana University School of Medicine, Indianapolis, IN
Ahmed Bilal Khalid , Rebecca Hassoun , Sandra K. Althouse , Tareq Salous , Clint Cary , Timothy A. Masterson , Lawrence H. Einhorn , Nabil Adra , Jennifer King
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Genitourinary Cancer—Prostate, Testicular, and Penile
Track
Genitourinary Cancer—Prostate, Testicular, and Penile
Sub Track
Germ Cell/Testicular Cancer
Citation
J Clin Oncol 42, 2024 (suppl 16; abstr 5035)
DOI
10.1200/JCO.2024.42.16_suppl.5035
Abstract #
5035
Poster Bd #
353
Abstract Disclosures
Similar Posters
Poster
2018 Genitourinary Cancers Symposium
Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumor patients.
First Author: Ricardo Romao Nazario Leao
Poster
2022 ASCO Annual Meeting
Management of residual nonretroperitoneal disease in nonseminomatous germ-cell tumors (NSGCT).
First Author: Jennifer King
Poster
2019 Genitourinary Cancers Symposium
Outcome of men with relapses after adjuvant BEP for clinical stage I nonseminoma.
First Author: Stefanie Christine Fischer
Poster
2019 Genitourinary Cancers Symposium
Clinical features and outcomes of secondary somatic malignancy (SSM) associated with primary mediastinal nonseminomatous germ cell tumors (PM-NSGCT).
First Author: Lucas W. Dean